a year ago
LONA
AnalystsGraig SuvannavejhGraig Suvannavejh's Stock Forecasts
AnalystsGraig Suvannavejh
Analyst Ranking
Top 10%
#485 out of 5170 analysts
Average Return
+11.08%
Win Rate
58%84 out of 146
Risk vs Reward
Poor
Good
Graig Suvannavejh's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Terns Pharmaceuticals IncTERN | +323.22% | $8.14 | $34.45 | 2025-10-21 - 2026-01-13 | Buy |
Insmed IncINSM | +266.11% | $20.36 | $74.54 | 2023-07-25 - 2024-07-26 | Strong Buy |
Amylyx Pharmaceuticals IncAMLX | +264.16% | $3.46 | $12.60 | 2025-04-06 - 2026-01-13 | Buy |
Insmed IncINSM | +197.15% | $23.88 | $70.96 | 2023-10-26 - 2024-10-25 | Strong Buy |
Amylyx Pharmaceuticals IncAMLX | +189.66% | $4.35 | $12.60 | 2025-05-13 - 2026-01-13 | Buy |
Graig Suvannavejh Analyst Color
Get additional color on Graig Suvannavejh's coverage of popular stocks
2 years ago
IMCR
2 years ago
ITCI
2 years ago
IMCR
2 years ago
EYPT
2 years ago
AXSM
2 years ago
ADVM
3 years ago
BTAI
3 years ago
ITCI
3 years ago
AXSM
3 years ago
AXSM
3 years ago
HRMY
Graig Suvannavejh's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Palvella Therapeutics IncPVLA | 1 | Buy | $205.00 | +97.99% | Initiates Coverage On | 8 days ago |
Erasca IncERAS | 1 | Buy | $5.00 | -33.38% | Maintains | a month ago |
Terns Pharmaceuticals IncTERN | 9 | Buy | $54.00 | +56.75% | Maintains | a month ago |
Belite Bio IncBLTE | 2 | Buy | $194.00 | +23.61% | Upgrades | a month ago |
Insmed IncINSM | 9 | Buy | $256.00 | +56.36% | Maintains | a month ago |
Harmony Biosciences Holdings IncHRMY | 21 | Buy | $46.00 | +28.64% | Maintains | a month ago |
Tarsus Pharmaceuticals IncTARS | 1 | Buy | $100.00 | +32.05% | Initiates Coverage On | 2 months ago |
Immatics NvIMTX | 4 | Buy | $23.00 | +145.20% | Maintains | 2 months ago |
Halozyme Therapeutics IncHALO | 5 | Hold | $56.00 | -21.86% | Maintains | 2 months ago |
Ideaya Biosciences IncIDYA | 3 | Buy | $46.00 | +31.09% | Maintains | 2 months ago |
Axsome Therapeutics IncAXSM | 22 | Buy | $202.00 | +15.87% | Maintains | 2 months ago |
Apellis Pharmaceuticals IncAPLS | 11 | Hold | $19.00 | -10.92% | Maintains | 2 months ago |
Bioxcel Therapeutics IncBTAI | 9 | Hold | $4.00 | +95.12% | Maintains | 4 months ago |
Kala Bio IncKALA | 1 | Buy | $30.00 | +4,826.11% | Initiates Coverage On | 4 months ago |
Alector IncALEC | 5 | Buy | $3.50 | +82.29% | Upgrades | 6 months ago |
Neumora Therapeutics IncNMRA | 2 | Buy | $5.00 | +133.64% | Maintains | 6 months ago |
Adverum Biotechnologies IncADVM | 5 | Buy | $12.00 | +175.23% | Maintains | 7 months ago |
Adaptimmune Therapeutics PLCADAPY | 3 | Hold | $0.50 | +825.93% | Downgrades | 7 months ago |
Immuneering CorpIMRX | 2 | Buy | $10.00 | +141.84% | Maintains | 7 months ago |
Corvus Pharmaceuticals IncCRVS | 3 | Buy | $11.00 | +69.23% | Maintains | 8 months ago |
Eyepoint Pharmaceuticals IncEYPT | 5 | Buy | $26.00 | +63.21% | Maintains | 8 months ago |
Amylyx Pharmaceuticals IncAMLX | 7 | Buy | $8.00 | -36.51% | Maintains | 8 months ago |
Immunocore Holdings PLCIMCR | 8 | Hold | $33.00 | +2.17% | Maintains | 9 months ago |
Intra Cellular Therapies IncITCI | 11 | Hold | $132.00 | +0.10% | Downgrades | a year ago |
Autolus Therapeutics PLCAUTL | 1 | Strong Buy | $7.60 | N/A | Upgrades | a year ago |
Corbus Pharmaceuticals Holdings IncCRBP | 1 | Buy | $74.00 | N/A | Reiterates | a year ago |
Leonabio IncLONA | 3 | Hold | $5.00 | N/A | Downgrades | a year ago |
Cerevel Therapeutics Holdings IncCERE | 9 | Hold | $45.00 | N/A | Maintains | 2 years ago |
Karuna Therapeutics IncKRTX | 3 | Strong Buy | $258.00 | N/A | Maintains | 2 years ago |
Rain Oncology IncRAIN2 | 5 | Hold | $1.00 | N/A | Downgrades | 3 years ago |
Vigil Neuroscience IncVIGL | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 3 years ago |
Rhythm Pharmaceuticals IncRYTM | 3 | Strong Buy | $35.00 | N/A | Maintains | 3 years ago |
Kodiak Sciences IncKOD | 4 | Hold | $8.00 | N/A | Maintains | 3 years ago |
Tg Therapeutics IncTGTX | 2 | Strong Sell | $26.00 | N/A | Downgrades | 4 years ago |
Disc Medicine IncIRON | 2 | Strong Buy | $18.00 | N/A | Maintains | 4 years ago |
Valneva SeVALN | 1 | Strong Buy | $34.00 | N/A | Initiates Coverage On | 5 years ago |
Design Therapeutics IncDSGN | 1 | Hold | $28.00 | N/A | Initiates Coverage On | 5 years ago |
Edgewise Therapeutics IncEWTX | 1 | Hold | $31.00 | N/A | Initiates Coverage On | 5 years ago |
Vor Biopharma IncVOR | 1 | Strong Sell | $380.00 | N/A | Initiates Coverage On | 5 years ago |
Innate Pharma SaIPHA | 1 | Hold | $4.75 | N/A | Initiates Coverage On | 5 years ago |
Arcutis Biotherapeutics IncARQT | 2 | Strong Buy | $36.00 | N/A | Upgrades | 5 years ago |
Cytokinetics IncCYTK | 1 | Hold | $16.00 | N/A | Initiates Coverage On | 5 years ago |
Galapagos NvGLPG | 1 | Strong Sell | N/A | N/A | Downgrades | 5 years ago |
Prelude Therapeutics IncPRLD | 1 | Hold | $37.00 | N/A | Initiates Coverage On | 5 years ago |
Jazz Pharmaceuticals PLCJAZZ | 1 | Strong Sell | $128.00 | N/A | Downgrades | 5 years ago |
Tricida IncTCDAQ | 1 | Hold | $10.00 | N/A | Downgrades | 5 years ago |
Flexion Therapeutics IncFLXN1 | 1 | Hold | $15.00 | N/A | Initiates Coverage On | 5 years ago |
Momenta Pharmaceuticals IncMNTA | 1 | Hold | $29.00 | N/A | Initiates Coverage On | 6 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 1 | Hold | $35.00 | N/A | Initiates Coverage On | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.